Company page

Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. is a public company traded under the ticker AMPH in the American market. With a market capitalization of approximately $829.4 million, the company focuses on developing and manufacturing injectable and inhalation pharmaceuticals. Amphastar is committed to providing high-quality products to improve patient outcomes.